Pharmaceuticals

Global Celiac Disease Treatment Market Overview: Trends Shaping Growth to 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Celiac Disease Treatment Industry Expected To Reach By 2029, Starting From 2025 Levels?

The celiac disease treatment market has experienced robust expansion in recent years. Its valuation is projected to rise from $0.61 billion in 2024 to $0.66 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.8%. This historical growth is driven by several factors, including an uptick in celiac disease prevalence, enhanced awareness and diagnosis rates, a rising need for non-dietary treatment alternatives, a robust array of innovative therapies in development, favorable regulatory support, and increased financial input from pharmaceutical firms.

The celiac disease treatment market is projected to experience robust expansion over the coming years. This market is anticipated to reach $0.94 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.3%. Factors contributing to this growth during the forecast period include the increasing global incidence of celiac disease, enhanced awareness and diagnosis, active clinical trials for new therapies, a growing preference for gluten-free options, supportive regulatory frameworks for orphan diseases, and increased spending on healthcare. Key trends expected within the forecast period involve the adoption of innovative non-dietary treatments, improvements in enzyme supplements, customized medicine strategies, the creation of peptide-based immunotherapies, better diagnostic instruments, and progress in clinical research.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp

Which Factors And Drivers Are Influencing The Celiac Disease Treatment Market In 2025?

The increasing incidence of diabetes is projected to drive the expansion of the celiac disease treatment market in the future. This condition is characterized by the body’s inability to adequately manage blood sugar or glucose levels over an extended period. The growing occurrence of diabetes stems from common dietary management requirements, given that both diabetes and celiac disease necessitate strict regulation of food intake to control blood sugar and avert complications. Celiac disease treatment supports individuals with diabetes by encouraging a gluten-free diet, which can enhance general digestive well-being and nutrient uptake. This approach contributes to improved blood sugar management and fewer complications for those dealing with both conditions. For example, data from June 2024, provided by the National Health Service, a UK government body, indicated that approximately 3,615,330 patients registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, representing an 18% rise from 3,065,825 cases recorded in 2022. Consequently, the expanding prevalence of diabetes is stimulating the growth of the celiac disease treatment market.

What Are The Leading Segments Analyzed In The Celiac Disease Treatment Market?

The celiac disease treatment market covered in this report is segmented –

1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments

2) By Enzyme Type: Distension, Diarrhoea, Anorexia, Bloating, Gas, Fatigue

3) By Diagnosis: Serological Tests, Genetic Testing, Biopsy

4) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels

Subsegments:

1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins

2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations

3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents

4) By Other Treatments: Probiotics, Immunotherapy, Stem Cell Therapy, Experimental Therapies

What Long-Term Trends Will Shape The Future Growth Of The Celiac Disease Treatment Industry?

Leading firms within the celiac disease treatment market are concentrating their efforts on creating oral therapeutic options, particularly small molecule therapies. These aim to deliver specific alleviation by impeding immunological reactions to gluten, enhancing patient compliance, and presenting substitutes for rigorous gluten-free dietary restrictions. Small molecule therapies are minute pharmacological agents capable of readily entering cells to precisely address and manage pathogenic proteins or enzymes. As an illustration, in February 2025, Immunic Inc., a US-based biotechnology firm, introduced IMU-856. IMU-856 functions as a small molecule that elevates endogenous glucagon-like peptide-1 (GLP-1) levels, thereby contributing to an enhanced intestinal barrier function in celiac disease patients. Furthermore, it boosts nutrient absorption and relieves symptoms without inhibiting immune system activity.

Which Major Firms Are Strengthening Their Position In The Celiac Disease Treatment Industry?

Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Celiac Disease Treatment Market?

North America was the largest region in the celiac disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Celiac Disease Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24186&type=smp

Browse Through More Reports Similar to the Global Celiac Disease Treatment Market 2025, By The Business Research Company

Autoimmune Disease Diagnosis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Granulocyte Colony Stimulating Factors Market 2025

https://www.thebusinessresearchcompany.com/report/granulocyte-colony-stimulating-factors-market

Autoimmune Disease Diagnosis Market 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795